1. Home
  2. PHVS vs SDA Comparison

PHVS vs SDA Comparison

Compare PHVS & SDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • SDA
  • Stock Information
  • Founded
  • PHVS 2015
  • SDA 2007
  • Country
  • PHVS Netherlands
  • SDA China
  • Employees
  • PHVS N/A
  • SDA N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • SDA Blank Checks
  • Sector
  • PHVS Health Care
  • SDA Finance
  • Exchange
  • PHVS Nasdaq
  • SDA Nasdaq
  • Market Cap
  • PHVS 1.0B
  • SDA 969.0M
  • IPO Year
  • PHVS 2021
  • SDA N/A
  • Fundamental
  • Price
  • PHVS $18.56
  • SDA $9.33
  • Analyst Decision
  • PHVS Strong Buy
  • SDA
  • Analyst Count
  • PHVS 5
  • SDA 0
  • Target Price
  • PHVS $40.60
  • SDA N/A
  • AVG Volume (30 Days)
  • PHVS 73.1K
  • SDA 346.9K
  • Earning Date
  • PHVS 11-13-2024
  • SDA 09-16-2024
  • Dividend Yield
  • PHVS N/A
  • SDA N/A
  • EPS Growth
  • PHVS N/A
  • SDA N/A
  • EPS
  • PHVS N/A
  • SDA N/A
  • Revenue
  • PHVS N/A
  • SDA $407,454,000.00
  • Revenue This Year
  • PHVS N/A
  • SDA $26.41
  • Revenue Next Year
  • PHVS N/A
  • SDA N/A
  • P/E Ratio
  • PHVS N/A
  • SDA N/A
  • Revenue Growth
  • PHVS N/A
  • SDA 28.51
  • 52 Week Low
  • PHVS $15.37
  • SDA $5.71
  • 52 Week High
  • PHVS $33.00
  • SDA $11.74
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 51.83
  • SDA 51.90
  • Support Level
  • PHVS $18.18
  • SDA $9.07
  • Resistance Level
  • PHVS $19.88
  • SDA $9.98
  • Average True Range (ATR)
  • PHVS 1.11
  • SDA 0.57
  • MACD
  • PHVS 0.17
  • SDA 0.10
  • Stochastic Oscillator
  • PHVS 76.86
  • SDA 70.66

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About SDA SunCar Technology Group Inc.

SunCar Technology Group Inc is a provider of digitalized enterprise automotive after-sales services and online auto insurance intermediation service in China. It operates an automotive after-sales services business through offering customized service solutions to enterprise clients, who are major banks, insurance companies, telecommunication companies, new energy vehicle, original equipment manufacturers or any client who have end customers demanding automotive services.

Share on Social Networks: